Faeth Therapeutics (FTH) Shares Issued (2020 - 2026)
Faeth Therapeutics' (FTH) quarterly Shares Issued came in at $2.7 million in Q1 2026, down 56.41% YoY from $6.1 million in Q1 2025, and up 881.91% on a QoQ basis from $272244.0 in Q4 2025.
Faeth Therapeutics (FTH) Shares Issued (2020 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 7 years of Shares Issued data on file, last reported at $2.7 million in Q1 2026.
- Quarterly Shares Issued fell 56.41% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (down 56.41% YoY) and the FY2025 annual result came in at $272244.0, up 2.83% from the prior year.
- Shares Issued rose to $2.7 million in Q1 2026, from $272244.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $6.1 million in Q1 2025 to a low of $159429.0 in Q2 2025.
- A 5-year average of $2.4 million and a median of $2.3 million in 2022 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2022 — Shares Issued surged 467.95% — and 2025, when it tumbled 96.5%.
- Tracing FTH's Shares Issued over 5 years: stood at $3.3 million in 2022, then gained by 2.58% to $3.4 million in 2023, then tumbled by 92.26% to $264741.0 in 2024, then advanced by 2.83% to $272244.0 in 2025, then jumped by 881.91% to $2.7 million in 2026.
- The last three Shares Issued figures came in at $2.7 million (Q1 2026), $272244.0 (Q4 2025), and $164204.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Faeth Therapeutics | 179.31 Mn | 179.31 Mn | - | 3.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.45 Mn |
| Jun 30, 2026 | 3.45 Mn |
| Mar 31, 2026 | 2.67 Mn |
| Mar 31, 2026 | 2.67 Mn |
| Dec 31, 2025 | 272,244.00 |
| Dec 31, 2025 | 272,244.00 |
| Sep 30, 2025 | 164,204.00 |
| Sep 30, 2025 | 164,204.00 |
| Jun 30, 2025 | 159,429.00 |
| Jun 30, 2025 | 159,429.00 |
| Mar 31, 2025 | 6.13 Mn |
| Mar 31, 2025 | 6.13 Mn |
| Dec 31, 2024 | 264,741.00 |
| Dec 31, 2024 | 264,741.00 |
| Sep 30, 2024 | 4.69 Mn |
| Sep 30, 2024 | 4.69 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 2.95 Mn |
| Mar 31, 2024 | 2.95 Mn |